We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 1,536 results
  1. The Role of Apelin and Protamine Sulfate in Bile Duct Ligation-Induced Liver Fibrosis in Rats

    This study was designed to investigate the effectiveness of protamine sulfate as an apelin receptor blocker on cholestatic liver fibrosis persuaded...

    Suzan M. M. Moursi, Eman El Bahaie, ... Sherein F. El-sayed in Pharmaceutical Chemistry Journal
    Article 28 December 2023
  2. The effect of new atypical antipsychotic drugs on the expression of transcription factors regulating cytochrome P450 enzymes in rat liver

    Background

    Our recent studies showed that prolonged administration of novel atypical antipsychotics affected the expression and activity of cytochrome...

    Przemysław J. Danek, Władysława A. Daniel in Pharmacological Reports
    Article Open access 15 June 2024
  3. Non-alcoholic fatty liver disease and liver secretome

    Metabolism of carbohydrates and lipids and protein degradation occurs in the liver and contributes to the body's homeostasis by secreting a variety...

    Muhammad Sohaib Khan, Choongho Lee, Sang Geon Kim in Archives of Pharmacal Research
    Article 28 November 2022
  4. Hyperoside attenuates pyrrolizidine alkaloids-induced liver injury by ameliorating TFEB-mediated mitochondrial dysfunction

    Pyrrolizidine alkaloids (PAs) are potent hepatotoxins that can cause liver damage. Hyperoside (Hyp), a natural flavonoid, can be extracted from...

    Jie Xu, Aizhen **ong, ... Li Yang in Archives of Pharmacal Research
    Article 01 August 2023
  5. The effect of brain serotonin deficit (TPH2-KO) on the expression and activity of liver cytochrome P450 enzymes in aging male Dark Agouti rats

    Background

    Liver cytochrome P450 (CYP) greatly contributes to the metabolism of endogenous substances and drugs. Recent studies have demonstrated that...

    Anna Haduch, Ewa Bromek, ... Władysława A. Daniel in Pharmacological Reports
    Article Open access 17 October 2023
  6. CYX-5, a G-protein biassed MOP receptor agonist, DOP receptor antagonist and KOP receptor agonist, evokes constipation but not respiratory depression relative to morphine in rats

    Background

    Strong opioid analgesics such as morphine alleviate moderate to severe acute nociceptive pain (e.g. post-surgical or post-trauma pain) as...

    Mohammad Zafar Imam, Andy Kuo, ... Maree T. Smith in Pharmacological Reports
    Article Open access 13 January 2023
  7. Oleuropein as a Therapeutic Agent for Non-alcoholic Fatty Liver Disease During Hepatitis C

    Hepatitis C is defined as an infection of hepatocytes by the hepatitis C virus that affects hepatocellular signaling pathways and can lead to...

    Mohammadjavad Sotoudeheian, SeyedAhmad Hoseini, ... Hamidreza Pazoki-Toroudi in Revista Brasileira de Farmacognosia
    Article 01 June 2023
  8. An Innovatory GABA Receptor Modulator and Liver Oxidase System Microsomal Cytochrome P450 Activator in Patients with Alcoholism

    Molecular docking studies (in Schrödinger and Glide software) showed that the molecule m-Cl-BHU ( meta -chlorobenzhydrylurea) is complementary to the...

    T. V. Shushpanova, N. A. Bokhan, ... E. M. Knyazeva in Pharmaceutical Chemistry Journal
    Article 02 February 2021
  9. Resveratrol Attenuates Non-alcoholic Fatty Liver Disease in Obese Mice Modulating MAF1

    In the present study, we aimed to evaluate the resveratrol effects on MAF1 liver pathway using a mice model of non-alcoholic fatty liver disease...

    Karinne Aparecida Souza Silva, Daniela Fernanda Freitas, ... Sergio Henrique Sousa Santos in Revista Brasileira de Farmacognosia
    Article 21 September 2022
  10. Regulation of NOX/p38 MAPK/PPARα pathways and miR-155 expression by boswellic acids reduces hepatic injury in experimentally-induced alcoholic liver disease mouse model: novel mechanistic insight

    Alcoholic liver disease (ALD) refers to hepatic ailments induced by excessive alcohol intake. The pathogenesis of ALD comprises a complex interplay...

    Rania M. Salama, Samah S. Abbas, ... Sara A. El Wakeel in Archives of Pharmacal Research
    Article Open access 23 March 2023
  11. Selected transgenic murine models of human autoimmune liver diseases

    Murine models of human diseases are of outmost importance for both studying molecular mechanisms driving their development and testing new treatment...

    Katarzyna Trzos, Natalia Pydyn, ... Jerzy Kotlinowski in Pharmacological Reports
    Article Open access 15 January 2022
  12. Voltage-clamp evidence of GABAA receptor subunit-specific effects: pharmacodynamic fingerprint of chlornordiazepam, the major active metabolite of mexazolam, as compared to alprazolam, bromazepam, and zolpidem

    Background

    Anxiolytic benzodiazepines, due to their clinical effectiveness, are one of the most prescribed drugs worldwide, despite being associated...

    Hélder Fernandes, Vânia Batalha, ... Patrício Soares-da-Silva in Pharmacological Reports
    Article 12 September 2022
  13. Agents for the treatment of fatty liver disease: focus on essential phospholipids

    Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in developed countries, with a prevalence that is increasing. In...

    Asad Izziddin Dajani, Adnan Abuhammour in Drugs & Therapy Perspectives
    Article Open access 10 May 2021
  14. Ganoderic acid A attenuates high-fat-diet-induced liver injury in rats by regulating the lipid oxidation and liver inflammation

    Ganoderic Acid A (GA) has many pharmacological effects such as anti-tumor, antibacterial, anti-inflammatory, and immunosuppressive effects. However,...

    Fuli Liu, Kejian Shi, ... Yujian Zhang in Archives of Pharmacal Research
    Article 26 July 2020
  15. Hepatic drug-metabolizing enzymes and drug transporters in Wilson’s disease patients with liver failure

    Background

    Wilson’s disease is a genetic disorder inherited in a recessive manner, caused by mutations in the copper-transporter ATP7B. Although it is...

    Sylwia Szeląg-Pieniek, Stefan Oswald, ... Mateusz Kurzawski in Pharmacological Reports
    Article Open access 11 June 2021
  16. Metabolic and cardiovascular benefits and risks of 4-hydroxy guanabenz hydrochloride: α2-adrenoceptor and trace amine-associated receptor 1 ligand

    Background

    α 2 -adrenoceptor ligands have been investigated as potential therapeutic agents for the treatment of obesity. Our previous studies have...

    Magdalena Kotańska, Monika Marcinkowska, ... Marcin Kołaczkowski in Pharmacological Reports
    Article Open access 25 August 2023
  17. Formyl peptide receptor 2, as an important target for ligands triggering the inflammatory response regulation: a link to brain pathology

    Formyl peptide receptors (FPRs) belong to the family of seven-transmembrane G protein-coupled receptors. Among them, FPR2 is a low affinity receptor...

    Kinga Tylek, Ewa Trojan, ... Agnieszka Basta-Kaim in Pharmacological Reports
    Article Open access 08 June 2021
  18. Investigation of Eurycoma longifolia Extract on Alleviating Steatosis by Using In Vivo and In Vitro Steatotic Models: Mechanisms Through Activation of AMPK and Autophagic Flux

    Eurycoma longifolia Jack, Simaroubaceae, is a popular tropical herb native to Southeast Asia, known for its medicinal properties. This study aimed to...

    Hsin-Ju Chen, Yu-Chi Chen, ... Yung-Chia Chen in Revista Brasileira de Farmacognosia
    Article 15 November 2023
  19. The reference liver—CYP450 and UGT enzymes in healthy donor and metastatic livers: the impact of genotype

    Background

    Hepatic enzymes involved in drug metabolism vary markedly in expression, abundance and activity, which affects individual susceptibility to...

    Mateusz Kurzawski, Sylwia Szeląg-Pieniek, ... Marek Droździk in Pharmacological Reports
    Article Open access 06 November 2021
  20. Emerging roles of ferroptosis in liver pathophysiology

    Ferroptosis is a widely recognized process of regulated cell death linking redox state, metabolism, and human health. It is considered a defense...

    Kyu Min Kim, Sam Seok Cho, Sung Hwan Ki in Archives of Pharmacal Research
    Article 20 October 2020
Did you find what you were looking for? Share feedback.